Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 20 matching records.
20 results — page 1 of 1
- Level BClinical TrialPubMed
Clinical efficacy and safety of allogeneic adipose-derived stem cells ELIXCYTE in chronic kidney disease: a phase I/II study.
Clinical Trial on Chronic Kidney Disease, published in Stem Cells Transl Med (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cells Transl Med - Level BClinical TrialPubMed
Preclinical safety and efficacy of an allogeneic adipose-derived mesenchymal stem cell medicinal product for rotator cuff repair: a two-phase experimental study.
Clinical Trial with a reported sample of 24 on Tendon Injury, Rotator Cuff, published in J Shoulder Elbow Surg (2026) — summary generated from the PubMed abstract.
- 2026
- n = 24
J Shoulder Elbow Surg - Level ASystematic ReviewPubMed
Clinical Safety and Efficacy of Allogeneic Adipose Stem Cells: A Systematic Review of the Clinical Trials.
Systematic Review with a reported sample of 953 on Osteoarthritis, Chronic Kidney Disease, Scar, Autoimmune Research, published in Int J Mol Sci (2025) — summary generated from the PubMed abstract.
- 2025
- n = 953
Int J Mol Sci2 citations - Level BClinical TrialPubMed
Safety and efficacy of long-shelf-life allogeneic adipose-derived mesenchymal stem cell line-derived platelet-like cells for refractory foot ulcers: A translational preclinical and phase 1/2a study.
Clinical Trial on Chronic Wound, published in Regen Ther (2025) — summary generated from the PubMed abstract.
- 2025
Regen Ther - Level BClinical TrialEurope PMC
Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cell transplantation in type 2 diabetes: a pilot clinical trial
Clinical Trial on Type 2 Diabetes, Chronic Inflammation, Immune Modulation, published in Am J Stem Cells (2025) — summary generated from the PubMed abstract.
- 2025
Am J Stem Cells - Level BClinical TrialPubMed
Efficacy and safety of autologous or allogeneic mesenchymal stromal cells from adult adipose tissue expanded and combined with tricalcium phosphate biomaterial for the surgical treatment of atrophic nonunion of long bone
Clinical Trial with a reported sample of 14, published in J Transl Med (2024) — summary generated from the PubMed abstract.
- 2024
- n = 14
J Transl Med10 citations - Level BRandomized Controlled TrialPubMed
Safety and efficacy of an allogeneic adipose-derived mesenchymal stem cell preparation in the treatment of knee osteoarthritis: A Phase I/IIa randomised controlled trial.
Randomized Controlled Trial with a reported sample of 40 on Knee Osteoarthritis, Osteoarthritis, published in Osteoarthr Cartil Open (2024) — summary generated from the PubMed abstract.
- 2024
- n = 40
Osteoarthr Cartil Open10 citations - Level CProspective StudyPubMed
Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Prospective Study with a reported sample of 46 on Immune Modulation, published in Ann Hematol (2023) — summary generated from the PubMed abstract.
- 2023
- n = 46
Ann Hematol - Level CProspective StudyPubMed
Evaluation of safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells in pediatric bronchiolitis obliterans syndrome (BoS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Prospective Study on Scar, Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cell Res Ther9 citations - Level BClinical TrialEurope PMC
Efficacy and safety of allogeneic umbilical cord-derived mesenchymal stem cells for the treatment of complex perianal fistula in Crohn's disease: a pilot study
Clinical Trial with a reported sample of 10 on Autoimmune Research, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
- n = 10
Stem Cell Res Ther14 citations - Level AMeta-analysisPubMed
PRISMA-Compliant Meta-Analysis of Randomized Controlled Trials on Osteoarthritis of Knee Managed with Allogeneic vs Autologous MSCs: Efficacy and Safety Analysis.
Meta-analysis with a reported sample of 936 on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in Indian J Orthop (2022) — summary generated from the PubMed abstract.
- 2022
- n = 936
Indian J Orthop10 citations - Level BRandomized Controlled TrialPubMed
Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: s
Randomized Controlled Trial with a reported sample of 30 on Type 2 Diabetes, Peripheral Artery Disease, published in Trials (2021) — summary generated from the PubMed abstract.
- 2021
- n = 30
Trials10 citations - Level BClinical TrialPubMed
Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis Patients, Single-Center, Prospective, Open-Label, Single-Arm Clinical Trial, Long-Term Follow-up.
Clinical Trial with a reported sample of 17 on Neuroinflammation, published in Cell J (2021) — summary generated from the PubMed abstract.
- 2021
- n = 17
Cell J7 citations - Level ARandomized Controlled TrialPubMed
A phase Ib/IIa, randomised, double-blind, multicentre trial to assess the safety and efficacy of expanded Cx611 allogeneic adipose-derived stem cells (eASCs) for the treatment of patients with community-acquired bacteria
Randomized Controlled Trial with a reported sample of 180 on Systemic / IV, published in BMC Pulm Med (2020) — summary generated from the PubMed abstract.
- 2020
- n = 180
BMC Pulm Med11 citations - Level BClinical TrialPubMed
Allogeneic Adipose-Derived Mesenchymal Stem Cells (Horse Allo 20) for the Treatment of Osteoarthritis-Associated Lameness in Horses: Characterization, Safety, and Efficacy of Intra-Articular Treatment.
Clinical Trial with a reported sample of 80 on Osteoarthritis, Chronic Inflammation, published in Stem Cells Dev (2018) — summary generated from the PubMed abstract.
- 2018
- n = 80
Stem Cells Dev26 citations - Level BClinical TrialPubMed
Allogeneic adipose-derived mesenchymal stem cell therapy in dogs with refractory atopic dermatitis: clinical efficacy and safety.
Clinical Trial on Immune Modulation, Autoimmune Research, published in Vet Rec (2018) — summary generated from the PubMed abstract.
- 2018
Vet Rec - Level DAnimal StudyPubMed
Safety and Efficacy of Allogeneic Lung Spheroid Cells in a Mismatched Rat Model of Pulmonary Fibrosis.
Animal Study, published in Stem Cells Transl Med (2017) — summary generated from the PubMed abstract.
- 2017
Stem Cells Transl Med - Level BClinical TrialEurope PMC
Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint
Clinical Trial on Osteoarthritis, published in Arthritis Res Ther (2016) — summary generated from the PubMed abstract.
- 2016
Arthritis Res Ther242 citations - Level BClinical TrialPubMed
Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Clinical and laboratory outcomes.
Clinical Trial on Autoimmune Research, published in Vet J (2015) — summary generated from the PubMed abstract.
- 2015
Vet J - Level DAnimal StudyPubMed
Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies.
Animal Study on Chronic Kidney Disease, published in Stem Cell Res Ther (2013) — summary generated from the PubMed abstract.
- 2013
Stem Cell Res Ther91 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406